We are live on ! Find out more
OCEA

Ocean Biomedical, Inc. Common Stock
OCEA

Delisted

OCEA was delisted on the 23rd of April, 2025.

Back to rankings

17 hedge funds and large institutions have $47.6M invested in Ocean Biomedical, Inc. Common Stock in 2023 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 37 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 2

56% less capital invested

Capital invested by funds: $108M → $47.6M (-$60.5M)

60% less funds holding

Funds holding: 43 → 17 (-26)

70% less first-time investments, than exits

New positions opened: 11 | Existing positions closed: 37

Holders
17
Holders Change
-26
Holders Change %
-60.47%
% of All Funds
0.27%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.03%
New
11
Increased
4
Reduced
2
Closed
37
Calls
$93K
Puts
–
Net Calls
+$93K
Net Calls Change
-$53K

Top Buyers

Rank Fund Capital Flow
1
PAMP
Polar Asset Management Partners
Ontario, Canada
+$20.7M
2
MC
Meteora Capital
Florida
+$14.8M
3
CCFM
Cohen & Co Financial Management
New York
+$12.8M
4
QL
Quarry LP
New York
+$1.94M
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$530K

Top Sellers

Rank Fund Capital Flow
1
SCM
Shaolin Capital Management
Florida
-$8.29M
2
SCM
Saba Capital Management
New York
-$7.63M
3
BFM
Boothbay Fund Management
New York
-$6.25M
4
ASM
ATW SPAC Management
New York
-$6.24M
5
WAM
Weiss Asset Management
Massachusetts
-$6.23M
Name Holding Trade Value Shares
Change 		Change in
Stake
CCM
26
Context Capital Management
California
– -$4.83M -464,841 Closed
MI
27
MMCAP International
Cayman Islands
– -$4.16M -400,000 Closed
YCM
28
Yakira Capital Management
Connecticut
– -$4.16M -400,000 Closed
WRBC
29
W.R. Berkley Corp
Connecticut
– -$3.82M -367,658 Closed
PC
30
Periscope Capital
Ontario, Canada
– -$3.06M -294,367 Closed
Marshall Wace
31
Marshall Wace
United Kingdom
– -$2.89M -277,624 Closed
CH
32
CVI Holdings
Delaware
– -$2.57M -246,832 Closed
KIM
33
Karpus Investment Management
New York
– -$2.48M -238,085 Closed
WP
34
Woodline Partners
California
– -$2.34M -225,000 Closed
6CM
35
683 Capital Management
New York
– -$1.56M -150,000 Closed
SV
36
Starboard Value
New York
– -$1.5M -144,169 Closed
KL
37
KIM LLC
Kansas
– -$1.41M -135,500 Closed
Calamos Advisors
38
Calamos Advisors
Illinois
– -$1.3M -125,000 Closed
WA
39
Whitebox Advisors
Minnesota
– -$1.07M -102,800 Closed
PSAMP
40
P. Schoenfeld Asset Management (PSAM)
New York
– -$835K -80,263 Closed
LA
41
Linden Advisors
New York
– -$817K -78,602 Closed
HCM
42
Highbridge Capital Management
New York
– -$815K -78,394 Closed
SFM
43
Spartan Fund Management
Canada
– -$771K -74,167 Closed
LCM
44
Landscape Capital Management
New Jersey
– -$759K -73,000 Closed
Walleye Capital
45
Walleye Capital
New York
– -$556K -53,498 Closed
DWM
46
Dakota Wealth Management
Florida
– -$448K -43,075 Closed
AA
47
AQR Arbitrage
Connecticut
– -$430K -41,347 Closed
CC
48
Centiva Capital
New York
– -$387K -37,180 Closed
Walleye Trading
49
Walleye Trading
New York
– -$374K -36,000 Closed
WAM
50
Warberg Asset Management
Illinois
– -$352K -33,809 Closed
1
2
3

OCEA Hedge Fund Activity: Q1 2023 in Review

17 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Ocean Biomedical, Inc. Common Stock (OCEA) for Q1 2023, worth a combined $47.6M — down 56% from $108M a quarter earlier.

Sellers outnumbered buyers: 37 funds closed out of OCEA and 11 opened new positions — a net loss of 26 holders — while 2 trimmed existing stakes and 4 added.

The largest buyer was Polar Asset Management Partners, adding an estimated $20.7M. The largest seller was Shaolin Capital Management, exiting entirely with an estimated $8.29M sold.

  • 17 institutional investors held Ocean Biomedical, Inc. Common Stock (OCEA) as of Q1 2023, down from 43 in Q4 2022.
  • Funds reported $47.6M of Ocean Biomedical, Inc. Common Stock stock for Q1 2023, down 56% quarter-over-quarter.
  • 11 funds opened new Ocean Biomedical, Inc. Common Stock positions in Q1 2023 and 37 closed out, a net change of -26 holders.
  • The largest Ocean Biomedical, Inc. Common Stock buyer in Q1 2023 was Polar Asset Management Partners, an estimated $20.7M added.
  • The largest Ocean Biomedical, Inc. Common Stock seller in Q1 2023 was Shaolin Capital Management, an estimated $8.29M sold.

Based on aggregated 13F filings for Q1 2023.